| Date Filed | Type | Description |
| 06/15/2022 |
4
| Flaherty Keith T. (Director) has filed a Form 4 on Kinnate Biopharma Inc.|
Txns:
| Granted 20,250 options to buy
@ $8.38, valued at
$169.7k
|
|
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2021 |
4
| Flaherty Keith T. (Director) has filed a Form 4 on Kinnate Biopharma Inc.|
Txns:
| Granted 20,250 options to buy
@ $24.46, valued at
$495.3k
|
|
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2020 |
3
| Flaherty Keith T. (Director) has filed a Form 3 on Kinnate Biopharma Inc. |
| 08/06/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/05/2020 |
4
| Flaherty Keith T. (Director) has filed a Form 4 on Clovis Oncology, Inc.|
Txns:
| Granted 40,138 options to buy
@ $6.48, valued at
$260.1k
|
|
| 06/07/2019 |
4
| Flaherty Keith T. (Director) has filed a Form 4 on Clovis Oncology, Inc.|
Txns:
| Granted 28,882 options to buy
@ $14.66, valued at
$423.4k
|
|
| 02/15/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/15/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2018 |
4
| Flaherty Keith T. (Director) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Granted 8,750 options to buy
@ $180.98, valued at
$1.6M
|
|
| 06/11/2018 |
4
| Flaherty Keith T. (Director) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 1,900 shares
@ $169.8458, valued at
$322.7k
Sold 5,021 shares
@ $171.153, valued at
$859.4k
Sold 4,634 shares
@ $172.0348, valued at
$797.2k
Sold 12,243 shares
@ $173.322, valued at
$2.1M
Sold 16,037 shares
@ $174.0446, valued at
$2.8M
Sold 4,743 shares
@ $175.1004, valued at
$830.5k
Sold 5,422 shares
@ $175.9712, valued at
$954.1k
Exercised 50,000 options to buy
@ $1.184, valued at
$59.2k
|
|
| 01/05/2018 |
4
| Flaherty Keith T. (Director) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Granted 2,500 options to buy
@ $84.88, valued at
$212.2k
|
|
| 11/22/2017 |
4
| Flaherty Keith T. (Director) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 4,489 shares
@ $75.3489, valued at
$338.2k
Sold 800 shares
@ $76.29, valued at
$61k
Sold 1,961 shares
@ $77.3321, valued at
$151.6k
|
|
| 08/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/24/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/23/2017 |
4
| Flaherty Keith T. (Director) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 7,250 shares
@ $41.4506, valued at
$300.5k
|
|
| 12/21/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/09/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/12/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/13/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |